Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 39

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 39
---
. Our non-employee directors currently consist of Michael Giuffre, M.D., Richard Kuntz, M.D., M.Sc., Tanya Lewis, Daniel O’Connor, James Parsons, Richard Pilnik, and Charles Semba, M.D. We use a combination of cash and long-term equity-based incentive compensation in the form of annual stock option grants and either deferred stock units or restricted stock units in lieu of cash retainers to attract and retain qualified candidates to serve on the Board of Directors. In setting non-employee director compensation, we follow the process and procedures described under “Corporate Governance—Compensation Committee—Processes and Procedures for the Determination of Director Compensation.”

On May 22, 2024, the Board approved, upon recommendation of the Compensation Committee, the following changes to our Non-Employee Director Compensation Program:

| ● | A $4,000 annual cash retainer for members of the new Scientific and Clinical Research Committee and an $8,000 annual cash retainer for the Chair of the Scientific and Clinical Research Committee; |

| ● | An increase in the annual equity award for non-employee directors from 0.06% to 0.075% of our outstanding common shares; and |

| ● | An increase in the initial equity award for new non-employee directors from 0.12% to 0.15% of our outstanding common shares. |

In recommending these changes, the Compensation Committee consulted with its independent compensation consultant, Alpine Rewards, LLC, and reviewed a competitive analysis prepared by Alpine Rewards that used the same peer group as used in reviewing our executive compensation program.

Cash Retainers. The following table sets forth the annual cash retainers paid to our non-employee directors during fiscal 2024:

| Description                                                            |     | Annual Cash 
 Retainer    |        |
|:-----------------------------------------------------------------------|:----|:------------|-------:|
| Board Member                                                           |     | $           | 40,000 |
| Chairman of the Board                                                  |     |             | 30,000 |
| Audit Committee Chair                                                  |     |             | 15,000 |
| Audit Committee Member (Excluding Chair)                               |     |             |  7,500 |
| Compensation Committee Chair                                           |     |             | 10,000 |
| Compensation Committee Member (Excluding Chair)                        |     |             |  5,000 |
| Nominating and Corporate Governance Committee Chair                    |     |             |  8,000 |
| Nominating and